A Single-centre, Open-label, Randomised, Single-dose Study to Evaluate the Effect of Pre- and Post-dose Meal Timings on the Pharmacokinetic Properties of Inno8 in Healthy Participants
Latest Information Update: 02 Dec 2025
At a glance
- Drugs Inno-8 (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
Most Recent Events
- 02 Dec 2025 New trial record